Insurtech unicorn production line looks strong but are valuations rational?
Two insurtechs attained unicorn status in Q1 and there were more additions to this growing club this month, with observers suggesting there are plenty more insurtechs on the production line that will make the grade this year either through new funding rounds or SPAC combinations.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below